Long-Term Feedback Effect of FGM in Newly-Diagnosed T2D Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 22, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions
Type 2 Diabetes
Interventions
DEVICE

flash glucose monitoring continuous

Group 2 (FGM continuous): will be asked to wear the sensor FreeStyle Libre2 for the FGM with the following frequency fashion continuously for the first 12 weeks and followed by 12 weeks testing as recommended by their usual provider.

DIAGNOSTIC_TEST

capillary blood test

Group 1 (SMBG): will be asked to test capillary blood glucose as recommended by subjects' usual provider for the first 12 weeks and followed by 12 weeks testing as recommended by their usual provider.

DEVICE

flash glucose monitoring intermittent

Group 3 (FGM intermittent): will be asked to wear the sensor FreeStyle Libre2 for the FGM with the following frequency fashion 1 week off/2 weeks on for the first 12 weeks and followed by 12 weeks testing as recommended by their usual provider.

Trial Locations (1)

00100

Fondazione Policlinico Universitario Campus Bio-Medico, Roma

All Listed Sponsors
lead

Campus Bio-Medico University

OTHER

NCT06098040 - Long-Term Feedback Effect of FGM in Newly-Diagnosed T2D Patients | Biotech Hunter | Biotech Hunter